HILLHOUSE INVESTMENT MANAGEMENT, LTD. [Rocket]

Date	Name	Symbol	Type	Security	Shares	Price	Value	Ownership	Reported
10/25/2021	Enfusion, Inc.		Sale	Class A common stock, par value $0.001 per share	647.9k	$15.90	$10.3M	See footnote	10/25/2021
11/13/2017	Apellis Pharmaceuticals, Inc.	APLS	Conversion	Series D Convertible Preferred Stock	4.5M	$0.00	$0	See footnotes	11/13/2017
11/13/2017	Apellis Pharmaceuticals, Inc.	APLS	Purchase	Common Stock	1.4M	$14.00	$20M	See footnotes	11/13/2017
11/13/2017	Apellis Pharmaceuticals, Inc.	APLS	Conversion	Common Stock	2.1M	$0.00	$0	See footnotes	11/13/2017
02/08/2016	BeiGene, Ltd.	BGNE	Conversion	Series A-2 Preferred Shares	15.8M	$0.00	$0	See footnotes	02/08/2016
02/08/2016	BeiGene, Ltd.	BGNE	Conversion	Series A Preferred Shares	14.8M	$0.00	$0	See footnotes	02/08/2016
02/08/2016	BeiGene, Ltd.	BGNE	Purchase	Ordinary Shares	9.1M	$0.00	$0	See footnotes	02/08/2016
02/08/2016	BeiGene, Ltd.	BGNE	Conversion	Ordinary Shares	30.6M	$0.00	$0	See footnotes	02/08/2016